Literature DB >> 17656260

Ossifying fibromyxoid tumor of soft parts with clonal chromosomal aberrations.

Hiroyuki Kawashima1, Akira Ogose, Hajime Umezu, Tetsuo Hotta, Tsuyoshi Tohyama, Masahiko Tsuchiya, Naoto Endo.   

Abstract

Ossifying fibromyxoid tumor (OFMT) is a rare but morphologically distinctive soft-tissue tumor. The histologic origin of this tumor is not clearly known, but its various features suggest a schwannian, neuronal, or chondroid origin. We herein report a case of a typical OFMT that occurred in the shoulder of a 65-year-old man. The karyotype exhibited the following complex numeric and structural aberrations: 42 approximately 46,XY,-Y,add(1)(q42),add(6)(p21),t(10;18)(q26;q11),der(11)t(11;15)(q23;q15),add(12)(q13),ins(14;?)(q13;?),-15,+mar. Combined with several previously reported studies, these aberrations could not identify a common cytogenetic abnormality in OFMT.

Entities:  

Mesh:

Year:  2007        PMID: 17656260     DOI: 10.1016/j.cancergencyto.2007.04.009

Source DB:  PubMed          Journal:  Cancer Genet Cytogenet        ISSN: 0165-4608


  4 in total

1.  Expanding the molecular signature of ossifying fibromyxoid tumors with two novel gene fusions: CREBBP-BCORL1 and KDM2A-WWTR1.

Authors:  Yu-Chien Kao; Yun-Shao Sung; Lei Zhang; Chun-Liang Chen; Shih-Chiang Huang; Cristina R Antonescu
Journal:  Genes Chromosomes Cancer       Date:  2016-08-26       Impact factor: 5.006

2.  Updates on the cytogenetics and molecular cytogenetics of benign and intermediate soft tissue tumors.

Authors:  Jun Nishio
Journal:  Oncol Lett       Date:  2012-10-30       Impact factor: 2.967

Review 3.  Ossifying fibromyxoid tumor invading the spine: a case report and review of the literature.

Authors:  Ji Hoon Cha; Jong Won Kwon; Eun Yoon Cho; Chong-Suh Lee; Young Cheol Yoon; Sang-Hee Choi
Journal:  Skeletal Radiol       Date:  2008-08-07       Impact factor: 2.199

4.  Imaging findings of ossifying fibromyxoid tumor with histopathological correlation: A case report.

Authors:  Soshi Ideta; Jun Nishio; Mikiko Aoki; Tetsuro Ishimatsu; Kazuki Nabeshima; Hiroshi Iwasaki; Masatoshi Naito
Journal:  Oncol Lett       Date:  2013-01-31       Impact factor: 2.967

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.